Regulation of muscarinic acetylcholine receptor signaling

Pharmacol Ther. 2003 May;98(2):197-220. doi: 10.1016/s0163-7258(03)00032-9.

Abstract

Multiple mechanisms regulate the signaling of the five members of the family of the guanine nucleotide binding protein (G protein)-coupled muscarinic acetylcholine (ACh) receptors (mAChRs). Following activation by classical or allosteric agonists, mAChRs can be phosphorylated by a variety of receptor kinases and second messenger-regulated kinases. The phosphorylated mAChR subtypes can interact with beta-arrestin and presumably other adaptor proteins as well. As a result, the various mAChR signaling pathways may be differentially altered, leading to short-term or long-term desensitization of a particular signaling pathway, receptor-mediated activation of the mitogen-activated protein kinase pathway downstream of mAChR phosphorylation, as well as long-term potentiation of mAChR-mediated phospholipase C stimulation. Agonist activation of mAChRs may also induce receptor internalization and down-regulation, which proceed in a highly regulated manner, depending on receptor subtype and cell type. In this review, our current understanding of the complex regulatory processes that underlie signaling of mAChR is summarized.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Down-Regulation
  • Humans
  • Ligands
  • Muscarinic Agonists / pharmacology*
  • Muscarinic Antagonists / pharmacology*
  • Phosphorylation
  • Receptors, Muscarinic / metabolism
  • Receptors, Muscarinic / physiology*
  • Signal Transduction / physiology*
  • Structure-Activity Relationship
  • Type C Phospholipases / pharmacology

Substances

  • Ligands
  • Muscarinic Agonists
  • Muscarinic Antagonists
  • Receptors, Muscarinic
  • Type C Phospholipases